Literature DB >> 33630021

Overcoming Barriers to Treatment of Opioid Use Disorder.

Yngvild Olsen1, Ruchi M Fitzgerald2, Sarah E Wakeman3.   

Abstract

Mesh：

Substances：

Year:  2021        PMID： 33630021     DOI： 10.1001/jama.2021.1741

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020.

Authors:  Jonathan Cantor; David Powell; Aaron Kofner; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2021-09-27       Impact factor: 4.492

2.  Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.

Authors:  Bradley D Stein; Brendan Saloner; Megan S Schuler; Jill Gurvey; Mark Sorbero; Adam J Gordon
Journal:  JAMA       Date:  2021-06-01       Impact factor: 56.272

3.  Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.

Authors:  Jessica J Wyse; Benjamin J Morasco; Jacob Dougherty; Beau Edwards; Devan Kansagara; Adam J Gordon; P Todd Korthuis; Anaïs Tuepker; Stephan Lindner; Katherine Mackey; Beth Williams; Anders Herreid-O'Neill; Robin Paynter; Travis I Lovejoy
Journal:  Drug Alcohol Depend       Date:  2021-07-29       Impact factor: 4.852

4.  How Physician Workforce Shortages Are Hampering the Response to the Opioid Crisis.

Authors:  Jennifer McNeely; Daniel Schatz; Mark Olfson; Noa Appleton; Arthur Robin Williams
Journal:  Psychiatr Serv       Date:  2021-09-15       Impact factor: 4.157

5.  Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX.

Authors:  Jennifer S Potter; Erin P Finley; Van L King; Holly J Lanham; Susanne Schmidt; Suyen Schneegans; Kristen D Rosen
Journal:  J Subst Abuse Treat       Date:  2021-12-13

6.  Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.

Authors:  Holly J Lanham; Jennifer Papac; Daniela I Olmos; Emily L Heydemann; Nathalia Simonetti; Susanne Schmidt; Jennifer S Potter
Journal:  JAMA Netw Open       Date:  2022-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.